Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,146 public trials 6,477 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

NCT06528301

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +19 more
Locations
  • City of Hope Duarte, California, United States
  • The David and Etta Jonas Center for Cellular Therapy Chicago, Illinois, United States
  • Washington University School of Medicine/Siteman Cancer Center St Louis, Missouri, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Recruiting

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

NCT04891289

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations
  • National Heart, Lung, and Blood Institute (NIH) (Data Collection Only) Bethesda, Maryland, United States
  • Washington University (Data Collection Only) St Louis, Missouri, United States
  • Memorial Sloan Kettering Basking Ridge - Limited Protocol Activities Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth - Limited Protocol Activities Middletown, New Jersey, United States
View Trial Details
Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

NCT07223021

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Cincinnati Children's Hospital Medical Center (Data Collection Only) Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia (Data Collection Only) Philadelphia, Pennsylvania, United States
  • Baylor College Medical Center (Data Collection Only) Houston, Texas, United States
View Trial Details
Recruiting

A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.

NCT06927466

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations
  • Peking University People's Hospital Beijing, China
  • Jiangxi Province pediatric hospital Nanchang, China
  • The First Affiliated Hospital of Nanchang University Nanchang, China
  • Children's Hospital of Shanghai Shanghai, China
View Trial Details
Recruiting

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

NCT07227012

Conditions
Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +13 more
Locations
  • Keck Hospital of USC Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 54 locations
View Trial Details

Related conditions